BlueSleep Forms Care Partnership with Shapely to Enhance Sleep Medicine and Weight-loss Services

BlueSleep, a digital platform specializing in the treatment of snoring and sleep apnea, has announced a new care partnership with Shapely, a virtual weight loss and wellness clinic. This collaboration aims to provide expedited access to essential treatments for patients suffering from sleep apnea, a condition notably prevalent in individuals experiencing obesity.

According to Jordan Stern, MD, Founder, and CEO of BlueSleep, the partnership emerges from a critical need to address the doubled rate of severe apnea found in obese individuals compared to those of a normal weight. By integrating care, they seek to mitigate the risks of related health issues like hypertension and heart disease through a comprehensive approach combining weight management and sleep disorder treatments.

Shapely offers an affordable subscription model that combines expert clinical advice with lifestyle modifications and weight loss medications, aiming for significant patient weight reduction. BlueSleep complements this by providing swift access to diagnosis and treatments for sleep disorders through its digital platform, promising immediate scheduling, home sleep tests, and various therapies while accepting major medical insurance and offering self-pay discounts.

Justin Zaghi, MD, Founder and CEO of Shapely, reiterates their mission to improve patient health outcomes by making healthcare more accessible. He views the partnership as a stride towards better health services for patients, aligning with both companies' commitment to affordable quality healthcare. The collaboration is projected to benefit patients by simplifying access to complementary health services.